Genetics
Prevalence and impact of the KIT M541L variant in patients with mastocytosis
A new research paper titled "Prevalence and impact of the KIT M541L variant in patients with mastocytosis" has been published in Oncotarget.
Jul 24, 2024
0
0
Oncotarget
Oncotarget is accepting papers on topics beyond oncology: Neuroscience, Endocrinology, Cardiology, Metabolism, Cell Biology, Pharmacology (all areas) and more
- Publisher
- Impact Journals
- History
- 2010 -
- Website
- http://www.impactjournals.com/oncotarget/
- Impact factor
- 5.168 (2016)
Medications
Study: Pembrolizumab combined with soluble EphB4-HSA shows promise in HPV-negative HNSCC
A new research paper published in Oncotarget is titled "Improved efficacy of pembrolizumab combined with soluble EphB4-albumin in HPV-negative EphrinB2 positive head neck squamous cell carcinoma."
Jul 22, 2024
0
0
Oncology & Cancer
DDX41 and its unique contribution to myeloid leukemogenesis
In an editorial paper published in Oncotarget titled, "DDX41 and its unique contribution to myeloid leukemogenesis," researcher Hirotaka Matsui from the National Cancer Center Hospital in Tokyo, Japan, and Kumamoto University ...
Jul 22, 2024
0
0
Oncology & Cancer
Researchers discuss HER2-low and HER2-zero in breast cancer
A new editorial paper titled "HER2-low and HER2-zero in breast cancer between prognosis, prediction and entity" has been published in Oncotarget.
Jul 16, 2024
0
0
Oncology & Cancer
Targeting ABC transporters in pancreatic ductal carcinoma—past, present, or future?
A new editorial paper titled "Targeting ABC transporters in PDAC—past, present, or future?" has been published in Oncotarget.
Jul 10, 2024
0
0
Medications
Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers: Study
A new research paper was published in Oncotarget titled, "Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers and overcomes cancer stemness, trifluridine-induced angiogenesis, ERK1/2 and STAT3 signaling ...
Jul 9, 2024
0
0
Oncology & Cancer
Study shows INT-1B3 inhibits distant tumor metastasis and significantly prolongs survival
A research paper has been published in Oncotarget titled, "INT-1B3, an LNP formulated miR-193a-3p mimic, promotes anti-tumor immunity by enhancing T cell mediated immune responses via modulation of the tumor microenvironment ...
7 hours ago
0
0
Oncology & Cancer
Prognostic and therapeutic insights into MIF, DDT, and CD74 in melanoma
A new research paper was published in Oncotarget entitled, "Prognostic and therapeutic insights into MIF, DDT, and CD74 in melanoma."
Jul 26, 2024
0
0
Oncology & Cancer
Researchers discuss metastatic castration resistant prostate cancer
A new editorial paper titled "Using early on-treatment circulating tumor DNA measurements as response assessment in metastatic castration resistant prostate cancer" has been published in Oncotarget.
Jul 17, 2024
0
1
Medications
Comparison of FDG-PET/CT and CT for treatment evaluation of patients with unresectable malignant pleural mesothelioma
A new research paper titled "Comparison of FDG-PET/CT and CT for evaluation of tumor response to nivolumab plus ipilimumab combination therapy and prognosis prediction in patients with unresectable malignant pleural mesothelioma" ...
Jul 15, 2024
0
0
